July 6, 2002 New Protease Inhibitor Has Added Benefits BARCELONA— Atazanavir, a potent new HIV-fighting protease inhibitor, reduces high cholesterol and triglyceride levels that may be caused by other protease inhibitors, a Northwestern University researcher reported today at the XIV International AIDS Conference. Although protease inhibitors have been shown to be safe and effective in[…]

NU-AID Volunteers Serve the Underserved in Nicaragua The Northwestern University Alliance for International Development (NU-AID), a medical school student organization, will bring free health services to the people of Nicaragua this June 22–30. Twenty-one students and four faculty physicians will set up clinics in and near the towns of Matagalpa and Jinotega. Dispensing some $200,000[…]

June 20, 2002 University Receives Grant to Study Oral Cancer CHICAGO— Oral cancer currently accounts for almost 6 percent of all malignancies, and its incidence is increasing worldwide. At least 90 percent of oral cancers are squamous cell carcinomas that originate from the oral epithelium, a thin lining of cells that covers tissues in the[…]